Navigation Links
Multi-Pronged Therapeutic Cancer Vaccine Regimen to be Studied in Melanoma Patients
Date:9/17/2008

-CSF and interferon-alpha-2b.

About the Clinical Trial

The randomized, open-label trial involves 120 participants at 23 centers across the United States and Canada. Stage IIIc, IVa and IVb melanoma patients with at least one measurable lesion and a life expectancy of at least six months will be included in the study. Participants will be randomized to one of two study groups. The first group will receive vaccine treatment consisting of a series of ALVAC and GM-CSF injections, followed by administration of interferon. The second group will receive administration of interferon alone.

The study is designed with the primary objective of progression-free survival (tumor stabilization) and the secondary objective of evaluation of safety, other efficacy endpoints (response rates), and the ability of the treatment regimen to induce an immune response.

The first cycle of vaccine treatment is conducted for a period of 16-weeks. If there is no evidence of disease progression during the first cycle, vaccine treatment is extended to a second 16 week cycle of treatment. In the study, patients in Group 2 whose disease has progressed during the first treatment cycle may be offered the vaccine regimen as the next cycle of treatment.

About Melanoma

Melanoma is the most serious form of skin cancer, accounting for 80 percent of all skin cancer deaths. Incidence and mortality rates for melanoma are rising faster than those for any other cancer. According to the American Cancer Society and Canadian Cancer Society, this year nearly 65,000 people in North America will be diagnosed with melanoma and more than 9,000 will die from the disease. By the year 2010, it is estimated that one in 50 people will have been diagnosed with melanoma. Standard treatments have minimal effect on survival, and sometimes cause significant toxicity.

About Therapeutic Cancer Vaccines

Therapeutic cancer vaccines represent an emerging, experimental type of
'/>"/>

SOURCE sanofi pasteur
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
3. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
4. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
5. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
6. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
7. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
8. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
9. Zila Inc. Product Selected to Identify Pre-Cancer in Study of Leading Cancer Treatment Chemotherapeutic - ERBITUX
10. Advanced Life Sciences to Present Data on Selected Cethromycin Therapeutic Studies at the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
11. TorreyPines Therapeutics Completes Phase I Multiple Dose Clinical Trial of NGX267, a Selective M1 Agonist for the Potential Treatment of Cognitive Impairment Associated with Schizophrenia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... 1, 2015 - ... R egistry data presented at ESC ... on the evolution of manag ing AF ... -   The first-ever two-year outcomes from the Global ... 2015 expose that all-cause death was the most frequent major event in more ...
(Date:9/1/2015)... Norway , September 1, 2015 ... biopharmaceutical company, today announces that it has appointed ... as Non-Executive Directors to its Board of Directors, effective ... 30 years of experience in pharma and biotech and ... Genzyme, a Sanofi company. Previously her role was Vice ...
(Date:8/31/2015)... The Indiana Medical Device Manufacturers Council and ... Sciences Policy Forum to state legislators. The new policy ... Diagnostics in Indianapolis and featured ... Ellspermann and State Sen. Brandt Hershman . ... new Learning & Development Center, which is under construction ...
Breaking Medicine Technology:Global Atrial Fibrillation Registry Presents Two-Year Outcomes Data In More Than 17,000 Newly Diagnosed AF Patients 2Global Atrial Fibrillation Registry Presents Two-Year Outcomes Data In More Than 17,000 Newly Diagnosed AF Patients 3Global Atrial Fibrillation Registry Presents Two-Year Outcomes Data In More Than 17,000 Newly Diagnosed AF Patients 4Global Atrial Fibrillation Registry Presents Two-Year Outcomes Data In More Than 17,000 Newly Diagnosed AF Patients 5Global Atrial Fibrillation Registry Presents Two-Year Outcomes Data In More Than 17,000 Newly Diagnosed AF Patients 6Global Atrial Fibrillation Registry Presents Two-Year Outcomes Data In More Than 17,000 Newly Diagnosed AF Patients 7Global Atrial Fibrillation Registry Presents Two-Year Outcomes Data In More Than 17,000 Newly Diagnosed AF Patients 8Global Atrial Fibrillation Registry Presents Two-Year Outcomes Data In More Than 17,000 Newly Diagnosed AF Patients 9BerGenBio Appoints Non-Executive Directors 2Indiana Lt. Gov. Sue Ellspermann and State Sen. Brandt Hershman Kick Off New Life Sciences Policy Series 2Indiana Lt. Gov. Sue Ellspermann and State Sen. Brandt Hershman Kick Off New Life Sciences Policy Series 3
... NEW YORK, Jan. 4, 2011 Reportlinker.com announces that a ... Cosmetic Surgery Products http://www.reportlinker.com/p060973/Cosmetic-Surgery-Products.html ... through 2014 Demand for products used in ... to $2.8 billion in 2014, when 16.1 million cosmetic procedures ...
... Jan. 3, 2011 Dynatronics Corporation (Nasdaq: ... of an agreement with Premier Purchasing Partners, L.P., the ... contracted supplier of physical therapy products and exercise equipment ... alternate market facilities.   Premier, Inc. is ...
Cached Medicine Technology:Reportlinker Adds Cosmetic Surgery Products 2Reportlinker Adds Cosmetic Surgery Products 3Dynatronics Named Contract Supplier to Premier, Inc. 2
(Date:9/1/2015)... ... , ... Horizon Blue Cross Blue Shield of New Jersey (BCBSNJ) has once ... Style 50 Report that recognizes companies that provide the best career opportunities for Hispanic ... from number 24 to 21 of the 50 Best Companies for Latinas. The LATINA ...
(Date:9/1/2015)... ... September 01, 2015 , ... ... to efficiently cure and prevent different malignancies. Some options for cancer treatment ... properties due to which distinctive approach is necessary for effective treatment. Several ...
(Date:9/1/2015)... ... September 01, 2015 , ... As part of ... Blue Shield of Minnesota (Blue Cross) has announced Doctor On Demand as the ... Francisco, Doctor On Demand provides immediate access to Board Certified physicians or next-day ...
(Date:9/1/2015)... ... September 01, 2015 , ... Negative pressure wound therapy (NPWT) ... to remove exudates, fluid, and infectious materials to prepare the wound for healing ... devices, and canisters, etc.) is projected to expand continuously through 2021. , Rising ...
(Date:9/1/2015)... ... September 01, 2015 , ... ... offering the MonaLisa Touch® , an innovative vaginal health laser procedure that ... a new hormone-free treatment for atrophic vaginitis, a condition that causes vaginal dryness, ...
Breaking Medicine News(10 mins):Health News:Horizon Blue Cross Blue Shield of New Jersey Named One of the 50 Best Companies for Latinas by Latina Style Magazine 2Health News:Horizon Blue Cross Blue Shield of New Jersey Named One of the 50 Best Companies for Latinas by Latina Style Magazine 3Health News:CD Antigen Cancer Market and Pipeline Landscape Examined in Comprehensive Kuick Research Report Published at MarketPublishers.com 2Health News:CD Antigen Cancer Market and Pipeline Landscape Examined in Comprehensive Kuick Research Report Published at MarketPublishers.com 3Health News:Blue Cross and Blue Shield of Minnesota names Doctor On Demand as preferred telehealth destination 2Health News:Blue Cross and Blue Shield of Minnesota names Doctor On Demand as preferred telehealth destination 3Health News:World Negative Pressure Wound Therapy Market Assessed by GlobalData in In-demand Report Published at MarketPublishers.com 2Health News:World Negative Pressure Wound Therapy Market Assessed by GlobalData in In-demand Report Published at MarketPublishers.com 3Health News:Houston's Plaza OB/GYN Now Offering the MonaLisa Touch® 2Health News:Houston's Plaza OB/GYN Now Offering the MonaLisa Touch® 3
... high incidence of Hepatitis A cases in Canterbury has prompted ... people have been infected with the deadly virus since December. ... on an average per year. ,The source of ... health reports. There possibility of some association between the three ...
... leptin hormone which is mostly produced in fats cells has ... to// Italian researchers. Giuseppe Matarese and colleagues from Università ... a possible way to both prevent and treat MS. ... in the regulation of food intake, metabolism, and the immune ...
... have identified a gene which gives rise to bipolar disorder ... found bipolar susceptibility genes, but this is the first time ... the researchers. ,The work might also explain ... more than 30 years, can help patients. But while lithium ...
... Professor Lee Kennedy and other medical experts from Townsville's James ... Queensland. ,The authour said that many studies are ... on the queenslanders. Research is mainly done on the obese ... a knoweledge of how the disease can be managed in ...
... at the University of Edinburgh in Scotland after an extensive ... is the most effective therapy. ,It is ... severe depression. Scientists say that despite the concerns it has ... the depressed mind. ,This research extended for a ...
... have a state-of-the-art heart and lung treatment centre at ... and lung surgery for patients across the west of ... UK, it will also be a national centre for ... procedures a year will be performed at the centre, ...
Cached Medicine News:Health News:Electroconvulsive Therapy Is The Treatment For Depression 2
... 1000 Power Instrument System is a ... versatility and convenience with modular and ... without hand throttle, for use with ... pedal. Accepts all 1000 and 2000 ...
... The Brasseler USA™ 2002 Battery Charger is manufactured ... The 2002 Battery Charger can charge up to ... minutes. The 2002 Charger is designed to operate ... there is a malfunction in the operation of ...
... diamond shaped teeth set the blade on a straight ... are very sharp, and the cut starts true, dancing ... with minimal force due to the sharp, smooth ground, ... , ,The troughs between the teeth provide ...
The High Speed Drill handpiece is a well-balanced, high performance drill that provides high speed for,bone sculpting, along with power for difficult osteotomies. Must be used with the 6401-000 foot ...
Medicine Products: